Notable Options Activity in Russell 3000 Index Components

Analyzing the options trading landscape reveals significant activity in TG Therapeutics Inc (Symbol: TGTX). So far today, traders have exchanged a total of 25,852 contracts, which corresponds to approximately 2.6 million underlying shares. This trading volume represents an impressive 158.3% of TGTX’s average daily trading volume over the past month, which stood at 1.6 million shares. Particularly, the $21 strike call option set to expire on May 16, 2025, has seen notable volume, with 1,797 contracts trading today, equivalent to roughly 179,700 underlying shares of TGTX. Below is a chart reflecting TGTX’s trading history, highlighting the $21 strike in orange:

Turning to Target Corp (Symbol: TGT), today’s options trading has reached a volume of 84,866 contracts. This volume translates to about 8.5 million underlying shares, resulting in a substantial 145.3% of TGT’s average daily trading volume, which is 5.8 million shares. A particularly noteworthy volume pertains to the $120 strike put option set to expire on March 07, 2025, with 5,529 contracts trading today, accounting for approximately 552,900 underlying shares of TGT. Below is TGT’s trading history chart, featuring the $120 strike highlighted in orange:

Additionally, Acuity Brands Inc (Symbol: AYI) shows a trading volume of 3,105 contracts today. This number corresponds to around 310,500 underlying shares, which represents 121.4% of AYI’s average daily trading volume over the last month, noted at 255,725 shares. The $290 strike put option expiring on March 21, 2025, is particularly active, with 1,545 contracts trading so far today, making up approximately 154,500 underlying shares of AYI. Below is a chart showing AYI’s trading history, with the $290 strike highlighted in orange:

For different expirations on TGTX, TGT, or AYI options, visit StockOptionsChannel.com.

Today’s Most Active Call & Put Options of the S&P 500 »

Also see:

• Dividend History
• Funds Holding STAA
• TYL Technical Analysis

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.